Track the Estrella Immunopharma, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €31.9m. The latest transaction was reported on 26 August 2026 (Levée d'options). Among the most active insiders: Xu Jiandong. The full history is free.
6
Insider Decl.
n/a
Thresholds
€2,213
3 ops.
Buy Volume
n/a
n/a
Sell Volume
46Σ signal
Buys €2,213n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.